retatrutide side effects trial results Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v retatrutide side effects clinical trials

Trimi states it holds LegitScript Healthcare Merchant Certification

Ozempic, containing Semaglutide GLP-1, mimics the GLP-1 hormone to reduce appetite and improve insulin sensitivity

Retatrutide treatment reduced blood glucose levels without achieving a full euglycaemia or preventing weight loss

The revised European Working Group on Sarcopenia in Older People, known as EWGSOP2, places low muscle strength at the center of the assessment

Retatrutide continues to gain attention in metabolic and weight management research for its multi-receptor activity as a promising medicine nd strong early data in clinical trials

Last reviewed: May 2026 Retatrutide is one of the most searched metabolic peptides in Thailand right now, and for good reason